About: Jonathan Sessler

An Entity of Type: animal, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

Jonathan Sessler (born 20 May 1956 in Urbana, Illinois) is a professor of chemistry at The University of Texas at Austin. He is notable for his pioneering work on expanded porphyrins and their applications to biology and medicine. He is a co-founder of Pharmacyclics, Inc., a company that works with expanded porphyrins, and Anionics, Inc., which develops anion recognition chemistry. Pharmacyclics was sold to AbbVie for $21 billion in 2015.

thumbnail
Property Value
dbo:abstract
  • Jonathan Sessler (born 20 May 1956 in Urbana, Illinois) is a professor of chemistry at The University of Texas at Austin. He is notable for his pioneering work on expanded porphyrins and their applications to biology and medicine. He is a co-founder of Pharmacyclics, Inc., a company that works with expanded porphyrins, and Anionics, Inc., which develops anion recognition chemistry. Pharmacyclics was sold to AbbVie for $21 billion in 2015. (en)
dbo:almaMater
dbo:birthDate
  • 1956-05-20 (xsd:date)
dbo:birthPlace
dbo:doctoralAdvisor
dbo:institution
dbo:thumbnail
dbo:wikiPageExternalLink
dbo:wikiPageID
  • 4385643 (xsd:integer)
dbo:wikiPageLength
  • 8302 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID
  • 1109741100 (xsd:integer)
dbo:wikiPageWikiLink
dbp:almaMater
  • Stanford University (en)
  • University of California (en)
dbp:birthDate
  • 1956-05-20 (xsd:date)
dbp:birthPlace
dbp:caption
  • Jonathan L. Sessler (en)
dbp:citizenship
  • American (en)
dbp:doctoralAdvisor
dbp:education
  • MSc at University of California, Berkeley (en)
  • PhD at Stanford University (en)
  • Postdoc at Louis Pasteur University (en)
dbp:name
  • Jonathan L. Sessler (en)
dbp:thesisYear
  • 1982 (xsd:integer)
dbp:wikiPageUsesTemplate
dbp:workplaces
dct:subject
gold:hypernym
rdf:type
rdfs:comment
  • Jonathan Sessler (born 20 May 1956 in Urbana, Illinois) is a professor of chemistry at The University of Texas at Austin. He is notable for his pioneering work on expanded porphyrins and their applications to biology and medicine. He is a co-founder of Pharmacyclics, Inc., a company that works with expanded porphyrins, and Anionics, Inc., which develops anion recognition chemistry. Pharmacyclics was sold to AbbVie for $21 billion in 2015. (en)
rdfs:label
  • Jonathan Sessler (en)
owl:sameAs
prov:wasDerivedFrom
foaf:depiction
foaf:isPrimaryTopicOf
foaf:name
  • Jonathan L. Sessler (en)
is dbo:doctoralStudent of
is dbo:foundedBy of
is dbo:wikiPageDisambiguates of
is dbo:wikiPageRedirects of
is dbo:wikiPageWikiLink of
is dbp:doctoralStudents of
is foaf:primaryTopic of
Powered by OpenLink Virtuoso    This material is Open Knowledge     W3C Semantic Web Technology     This material is Open Knowledge    Valid XHTML + RDFa
This content was extracted from Wikipedia and is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License